Status:
TERMINATED
Cognitive Training in Stroke Rehabilitation
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Executive Dysfunction
Cognitive Impairment
Eligibility:
All Genders
30-89 years
Phase:
NA
Brief Summary
This is a randomized, controlled pilot study to evaluate the efficacy of "ASCEND-I" (A Strategy and Computer-based intervention to ENhance Daily cognitive functioning after stroke - Inpatient), an inp...
Eligibility Criteria
Inclusion
- Patient admitted for a stroke and accepted to acute inpatient rehabilitation at NYP-Weill Cornell.
- Age 30-89
- English speaking
- Ability to comprehend sufficiently to participate in the treatment
- Mild-moderate cognitive impairment as determined by a standard of care cognitive screening tools administered by occupational therapists (e.g., Montreal Cognitive Assessment, Symbol-Digit Modalities Test, or other clinical standard of care instrument). We will review subjects' most recent cognitive assessment administered by OT (Occupational Therapists) and available in the EMR (Electronic Medical Records) to determine eligibility.
- Willingness to participate in full study duration
- Physically able to operate a computer keyboard, tablet/iPad, and mouse.
Exclusion
- History of other neurologic disorder (e.g., Parkinson's disease, Multiple Sclerosis, Alzheimer's disease, brain tumor). History of previous stroke(s) will not be exclusionary as long as the subject does not self-report having lasting/persistent cognitive impairment from the prior stroke.
- History of severe mental illness (e.g., schizophrenia, psychosis) or substance use disorder, recent history (in the past year) of alcohol/substance use disorder or symptoms of psychosis. Note that the presence of post-stroke depression will not be grounds for exclusion.
- History of dementia
- Moderate-severe hemispatial neglect as determined by OT evaluation
- Any factor that in the investigator's opinion is likely to compromise the subject's ability to participate in the study, including evidence that the subject may not understand and/or adhere to study requirements
Key Trial Info
Start Date :
January 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04472351
Start Date
January 12 2021
End Date
September 15 2022
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065